By Fineline Cube 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd’s (SHA: 600196, HKG: 2196) subsidiary Fosun Diagnostics (Shanghai) Co., Ltd has partnered with Germany-based Siemens Healthineers AG (ETR: SHL) to launch their first co-developed product—a locally-produced biochemical reagent solution. The product is developed based on Siemens Healthineers’ Atellica domestic high-end testing platform and features biochemical testing reagents locally researched and manufactured by Fosun Diagnostics.
Product Features
The biochemical reagent solution covers multiple testing areas, including liver function, kidney function, cardiac enzymes, and glucose metabolism. It is scheduled for official market launch later this year.
Collaboration History
Since 2019, the two companies have been collaborating on several domestically-produced biochemical reagent solutions.-Fineline Info & Tech